AnaptysBio Inc
ANAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.67B
Close$
$-14.56
126.1% downside
Current Fair Value
126.1% downsideOvervalued by 126.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.70 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.46 |
| Beta | 0.4 |
| Outstanding Shares | 28,691,000 |
Return
| Return on Equity | -210.14% |
|---|---|
| Return on Assets | -8.13% |
| Return on Invested Capital | 10.96% |
Valuation & Multiples
| P/E Ratio | -64.69 |
|---|---|
| PEG | -187.69 |
| Price to Sales | 6.98 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.29 |
| Enterprise Value to EBIT | 53.72 |
| Enterprise Value to Net Income | -64 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 21.76 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$6.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$6.97 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.6410▲ 142.59% |
|---|---|
| Total Calls | 50,700▲ 101.99% |
| Total Puts | 83,200▲ 1440.74% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.82%▼ 37.80% |
|---|---|
| Total Invested | $2.08B▲ 34.16% |
| Investors Holding | 220▲ 10.00% |
ESG Score
No data
About AnaptysBio Inc
CEO: Hamza Suria